{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T11:52:18Z","timestamp":1782733938608,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.rmed.2017.07.012","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T10:01:28Z","timestamp":1500458488000},"page":"75-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Effects of inhaled corticosteroids \/long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002\u20132013"],"prefix":"10.1016","volume":"130","author":[{"given":"Kyoung Hee","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Sam","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Linton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung Mo","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2306-5398","authenticated-orcid":false,"given":"Eun-Cheol","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2017.07.012_bib1","author":"Global Initiative for Chronic Obstructive Lung Disease (GOLD)"},{"issue":"3","key":"10.1016\/j.rmed.2017.07.012_bib2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3109\/15412555.2011.648030","article-title":"Chronic obstructive pulmonary disease and socioeconomic status: a systematic review","volume":"9","author":"Gershon","year":"2012","journal-title":"COPD"},{"issue":"4","key":"10.1016\/j.rmed.2017.07.012_bib3","article-title":"Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease","volume":"17","author":"Nannini","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.rmed.2017.07.012_bib4","first-page":"18","article-title":"Inhaled corticosteroids for stable chronic obstructive pulmonary disease","author":"Yang","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"issue":"8","key":"10.1016\/j.rmed.2017.07.012_bib5","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"8","key":"10.1016\/j.rmed.2017.07.012_bib6","article-title":"Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease","volume":"30","author":"Nannini","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"9356","key":"10.1016\/j.rmed.2017.07.012_bib7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(03)12459-2","article-title":"Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial","volume":"361","author":"Calverley","year":"2003","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.rmed.2017.07.012_bib8","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.rmed.2010.09.008","article-title":"Beclomethasone\/formoterol in the management of COPD: a randomised controlled trial","volume":"104","author":"Calverley","year":"2010","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2017.07.012_bib9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1183\/09031936.00128914","article-title":"Inhaled corticosteroids in COPD: the clinical evidence","volume":"45","author":"Ernst","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.rmed.2017.07.012_bib10","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1164\/rccm.200502-210OC","article-title":"Inhaled corticosteroids in chronic obstructive pulmonary disease: results from two observational designs free of immortal time bias","volume":"172","author":"Kiri","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2017.07.012_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1164\/rccm.200210-1231OC","article-title":"Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies","volume":"168","author":"Suissa","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10030","key":"10.1016\/j.rmed.2017.07.012_bib12","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(16)30069-1","article-title":"Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial","volume":"387","author":"Vestbo","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.rmed.2017.07.012_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1185\/03007995.2011.636420","article-title":"Efficacy and safety of budesonide\/formoterol via a dry powder inhaler in Chinese patients with chronic obstructive pulmonary disease","volume":"28","author":"Zhong","year":"2012","journal-title":"Curr. Med. Res. Opin."},{"issue":"3","key":"10.1016\/j.rmed.2017.07.012_bib14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.rmed.2011.09.004","article-title":"Korean Academy of Tuberculosis and Respiratory Diseases study group; Korea Chronic Obstructive Pulmonary Disease study group., Comparison of tiotropium plus fluticasone propionate\/salmeterol with tiotropium in COPD: a randomized controlled study","volume":"106","author":"Jung","year":"2012","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2017.07.012_bib15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pupt.2014.08.002","article-title":"Comparison of airway dimensions with once daily tiotropium plus indacaterol versus twice daily Advair((R)) in chronic obstructive pulmonary disease","volume":"30","author":"Hoshino","year":"2015","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.rmed.2017.07.012_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/1753465816630208","article-title":"Inhaled corticosteroids and the increased risk of pneumonia: what's new? A 2015 updated review","volume":"10","author":"Iannella","year":"2016","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"3","key":"10.1016\/j.rmed.2017.07.012_bib17","article-title":"Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease","volume":"10","author":"Kew","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"8","key":"10.1016\/j.rmed.2017.07.012_bib18","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/thx.2011.160028","article-title":"Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies","volume":"66","author":"Loke","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2017.07.012_bib19","first-page":"37","article-title":"Introduction of health insurance review and assessment services' national patients sample","author":"Kim","year":"2012","journal-title":"Wonju HIRA Policy Trends"},{"key":"10.1016\/j.rmed.2017.07.012_bib20","series-title":"Design and Testing of Data Linkage System Betwwen KNHANES and Other Secondary Administrative Data. Chung-ju: Korea Centers for Diseases and Prevention","author":"Chang","year":"2013"},{"issue":"1","key":"10.1016\/j.rmed.2017.07.012_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.rmed.2013.08.003","article-title":"The association between inhaled long-acting bronchodilators and less in-hospital care in newly-diagnosed COPD patients","volume":"108","author":"Kim","year":"2014","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2017.07.012_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2016.03.003","article-title":"Effects of individual and neighborhood socioeconomic status on the risk of all-cause mortality in chronic obstructive pulmonary disease: a nationwide population-based cohort study, 2002-2013","volume":"114","author":"Cho","year":"2016","journal-title":"Respir. Med."},{"issue":"5","key":"10.1016\/j.rmed.2017.07.012_bib23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J.\u00a0Chronic Dis."},{"issue":"4","key":"10.1016\/j.rmed.2017.07.012_bib24","first-page":"209","article-title":"Combination therapy in COPD: different response of COPD stages and predictivity of functional parameters","volume":"9","author":"Terzano","year":"2005","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"178","key":"10.1016\/j.rmed.2017.07.012_bib25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1471-2466-14-178","article-title":"Efficacy and safety of aclidinium bromide\/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study","volume":"14","author":"Singh","year":"2014","journal-title":"BMC Pulm. Med."},{"issue":"10","key":"10.1016\/j.rmed.2017.07.012_bib26","first-page":"1015","article-title":"LANTERN Investigators., LANTERN: a randomized study of QVA149 versus salmeterol\/fluticasone combination in patients with COPD","volume":"5","author":"Zhong","year":"2015","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"issue":"3","key":"10.1016\/j.rmed.2017.07.012_bib27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S2213-2600(13)70052-3","article-title":"Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study","volume":"1","author":"Wedzicha","year":"2013","journal-title":"Lancet Respir. Med."},{"issue":"6","key":"10.1016\/j.rmed.2017.07.012_bib28","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1378\/chest.08-3016","article-title":"Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study","volume":"136","author":"Ferguson","year":"2009","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rmed.2017.07.012_bib29","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1378\/chest.124.3.834","article-title":"The efficacy and safety of fluticasone propionate (250 microg)\/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD","volume":"124","author":"Hanania","year":"2003","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2017.07.012_bib30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1183\/09031936.03.00031402","article-title":"Efficacy and safety of budesonide\/formoterol in the management of chronic obstructive pulmonary disease","volume":"21","author":"Szafranski","year":"2003","journal-title":"Eur. Respir. J."},{"issue":"6 Suppl","key":"10.1016\/j.rmed.2017.07.012_bib31","doi-asserted-by":"crossref","first-page":"S298","DOI":"10.1067\/mai.2002.129703","article-title":"The effect of inhaled beta2-agonists on clinical outcomes in chronic obstructive pulmonary disease","volume":"110","author":"Mahler","year":"2002","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"issue":"10076","key":"10.1016\/j.rmed.2017.07.012_bib32","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(16)32381-9","article-title":"Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble","volume":"389","author":"Kontis","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2017.07.012_bib33","series-title":"The Life Expectancy and Health-adjusted Life Expectancy of Koreans. Sejong:Korea Institute for Health and Social Affairs","author":"Ko","year":"2014"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611117302123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611117302123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:36:54Z","timestamp":1760614614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611117302123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":33,"alternative-id":["S0954611117302123"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2017.07.012","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of inhaled corticosteroids \/long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002\u20132013","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2017.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}